SCHEMBL210505

SCHEMBL210505

COC(=O)c1ccc(-c2cc(Cl)c([C@H](C3CCOCC3)C3CCNC3=O)c(Cl)c2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 1/20 0.37
RHEB Q15382 1/20 0.36
ALDH1A1 P00352 4/20 0.36
ALOX15 P16050 2/20 0.36
HPGD P15428 1/20 0.36
MGLL Q99685 1/20 0.36
HSD17B10 Q99714 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3R2 O00459 1/20 0.36
BRD4 O60885 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
PIK3CG P48736 1/20 0.36
MAPT P10636 2/20 0.35
POLB P06746 2/20 0.35
WNT3A P56704 1/20 0.35
TNKS2 Q9H2K2 1/20 0.35
SLC6A3 Q01959 1/20 0.35
MAPK1 P28482 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL208481 0.90 SLC6A3 (0.41) RHEBALDH1A1ALOX15HSD17B10MAPT
SCHEMBL4067647 0.88 POLB (0.37) CSF1RALDH1A1PIK3CDBRD4PIK3CA
SCHEMBL209419 0.88 POLB (0.37) CSF1RALDH1A1PIK3CDBRD4PIK3CA
SCHEMBL207570 0.84 MAP2K4 (0.35) RHEBALDH1A1MAPTSLC6A3KDM4E
SCHEMBL208452 0.80 PDE4D (0.35) SLC6A3
SCHEMBL2999303 0.79 SLC6A3 (0.40) ALDH1A1HSD17B10SLC6A3SMN1; SMN2MEN1
SCHEMBL4180949 0.79 BMPR1B (0.43) HPGDSLC6A3KMT2A
SCHEMBL3453529 0.79 MEN1 (0.34) RHEBALDH1A1HPGDMAPTWNT3A
SCHEMBL2994149 0.78 ALDH1A1 (0.35) RHEBALDH1A1ALOX15HSD17B10MAPT
SCHEMBL2065311 0.78 ALDH1A1 (0.40) ALDH1A1ALOX15HPGDHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2016047-B1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11- BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2013-08-28 EP disclosed
US-8088776-B2 Biphenyl amide lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2012-01-03 US disclosed
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156571-A1 BIPHENYL AMIDE LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD11B2 CSF1R 1451/4885RHEB 2359/4885ALDH1A1 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.